Physician profile
Milan J Joshi
NPI 1194968263
$6,067.18
in general payments reported to CMS, 2019-2025
19 companies · $1,372 in 2025
The $1,372 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $230 · 2020: $397 · 2021: $491 · 2022: $1,915 · 2023: $689 · 2024: $972 · 2025: $1,372.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,034.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,033.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $2,469.25 | 2019-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Imperative Care, INC | $993.94 | 2021-2025 | Zoom 88-T Large Distal Platform, Zoom Reperfusion Catheter, Zoom 7x Catheter |
| Penumbra, INC. | $597.61 | 2021-2025 | Indigo System, Smart Coil, Red 72 |
| Allergan, INC. | $518.71 | 2019-2020 | |
| Stryker Corporation | $503.97 | 2025 | Clottriever Bold Catheter, Flowtriever, Revcore Thrombectomy Catheter |
| Abbvie INC. | $187.31 | 2021-2022 | |
| Boston Scientific Corporation | $176.53 | 2020-2025 | Embold Fibered |
| Medtronic, INC. | $158.36 | 2022-2025 | Concertotm, Protege Rx, Abre |
| Bard Peripheral Vascular, INC. | $99.86 | 2021-2025 | Pristine |
| Cook Medical LLC | $79.01 | 2021-2023 | Zilver Ptx |
| Angiodynamics, INC. | $73.95 | 2021-2025 | Alphavac |
| Neos Therapeutics, LP | $41.69 | 2021 | |
| Sirtex Medical INC | $30.34 | 2024-2025 | Sir-Spheres Microspheres, Lava Les (Liquid Embolic System) |
| Biogen, INC. | $29.05 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $27.56 | 2025 | Austedo Xr |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $24.71 | 2022 | |
| Abbott Laboratories | $24.43 | 2023 | Jeti Peripheral Catheter |
| Celgene Corporation | $16.01 | 2025 | Reblozyl |
| Nevro Corp. | $14.89 | 2024 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Milan Joshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.